$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

$mlss Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000143774922012645 Filed on May 16, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$2.701M	$2.925M
YoY Change	-7.65%	61.46%
Cost Of Revenue	$1.018M	$1.122M
YoY Change	-9.26%	112.88%
Gross Profit	$1.682M	$1.802M
YoY Change	-6.65%	40.35%
Gross Profit Margin	62.29%	61.62%
Selling, General & Admin	$3.116M	$2.749M
YoY Change	13.32%	0.05%
% of Gross Profit	185.19%	152.54%
Research & Development	$464.5K	$16.44K
YoY Change	2724.53%	-84.7%
% of Gross Profit	27.61%	0.91%
Depreciation & Amortization	$16.81K	$20.92K
YoY Change	-19.64%	-43.78%
% of Gross Profit	1.0%	1.16%
Operating Expenses	$3.597M	$2.787M
YoY Change	29.08%	-3.67%
Operating Profit	-$1.914M	-$984.4K
YoY Change	94.49%	-38.81%
Interest Expense	-$4.740K	-$2.540K
YoY Change	86.61%	-2409.09%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.919M	-$986.9K
YoY Change	94.47%	-38.8%
Income Tax	$0.00	$250.00
% Of Pretax Income
Net Earnings	-$1.900M	-$972.9K
YoY Change	95.3%	-39.2%
Net Earnings / Revenue	-70.35%	-33.26%
Basic Earnings Per Share	-$0.03	-$0.01
Diluted Earnings Per Share	-$0.03	-$0.01
COMMON SHARES
Basic Shares Outstanding	69.01M	66.58M
Diluted Shares Outstanding	69.01M	66.58M

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.25M	$16.95M
YoY Change	-21.8%	2112.94%
Cash & Equivalents	$13.25M	$16.95M
Short-Term Investments
Other Short-Term Assets	$622.1K	$688.8K
YoY Change	-9.69%	-2.57%
Inventory	$1.800M	$2.021M
Prepaid Expenses
Receivables	$1.064M	$978.8K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$18.23M	$21.66M
YoY Change	-15.84%	311.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.33K	$27.07K
YoY Change	-24.93%	-9.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$24.15K	$24.15K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$837.6K	$981.7K
YoY Change	-14.68%	-11.83%
TOTAL ASSETS
Total Short-Term Assets	$18.23M	$21.66M
Total Long-Term Assets	$837.6K	$981.7K
Total Assets	$19.07M	$22.64M
YoY Change	-15.79%	255.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.012M	$694.0K
YoY Change	45.83%	-51.93%
Accrued Expenses	$1.335M	$1.179M
YoY Change	13.28%	41.64%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$276.2K
YoY Change	-100.0%
Long-Term Debt Due	$8.740K	$7.980K
YoY Change	9.52%
Total Short-Term Liabilities	$3.827M	$3.039M
YoY Change	25.92%	-42.01%
LONG-TERM LIABILITIES
Long-Term Debt	$17.80K	$26.54K
YoY Change	-32.93%	-23.12%
Other Long-Term Liabilities	$454.9K	$538.4K
YoY Change	-15.52%	-12.03%
Total Long-Term Liabilities	$472.7K	$565.0K
YoY Change	-16.34%	-12.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.827M	$3.039M
Total Long-Term Liabilities	$472.7K	$565.0K
Total Liabilities	$4.299M	$3.604M
YoY Change	19.29%	-38.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$109.6M	-$101.9M
YoY Change	7.6%	7.08%
Common Stock	$125.5M	$121.9M
YoY Change	2.9%	26.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$911.5K	$911.5K
YoY Change	0.0%	0.0%
Treasury Stock Shares	$33.33K	$33.33K
Shareholders Equity	$14.94M	$19.14M
YoY Change
Total Liabilities & Shareholders Equity	$19.07M	$22.64M
YoY Change	-15.79%	255.18%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$1.900M	-$972.9K
YoY Change	95.3%	-39.2%
Depreciation, Depletion And Amortization	$16.81K	$20.92K
YoY Change	-19.64%	-43.78%
Cash From Operating Activities	-$1.508M	-$967.8K
YoY Change	55.76%	-0.44%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$5.916K
YoY Change	-100.0%	-17.12%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$5.916K
YoY Change	-100.0%	-17.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$2.063K	$3.701M
YoY Change	-100.06%	1516.51%
NET CHANGE
Cash From Operating Activities	-$1.508M	-$967.8K
Cash From Investing Activities	$0.00	-$5.916K
Cash From Financing Activities	-$2.063K	$3.701M
Net Change In Cash	-$1.510M	$2.727M
YoY Change	-155.36%	-463.43%
FREE CASH FLOW
Cash From Operating Activities	-$1.508M	-$967.8K
Capital Expenditures	$0.00	$5.916K
Free Cash Flow	-$1.508M	-$973.7K
YoY Change	54.82%	-0.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	68432335
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68153336
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68153336
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23713	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	68153	USD
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68120003
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	264192	USD
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68120003
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	277619	USD
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	17801	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	20062	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	454857	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	476980	USD
CY2022Q1	us-gaap	Liabilities Liabilities	4299264	USD
CY2021Q4	us-gaap	Liabilities Liabilities	3594362	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2022Q1	us-gaap	Open Tax Year OpenTaxYear	2018 2019 2020
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2021Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M18D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13254775	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14764346	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1063613	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	943272	USD
CY2022Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	269973	USD
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	0	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	622080	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	375360	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	1799908	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	1541513	USD
CY2022Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	1217253	USD
CY2021Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	1309260	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	18227602	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	18933751	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20325	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	528907	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	550511	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24150	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24150	USD
CY2022Q1	us-gaap	Assets Assets	19065176	USD
CY2021Q4	us-gaap	Assets Assets	19809744	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1012093	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	780428	USD
CY2022Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1128919	USD
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	395857	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1335451	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1417248	USD
CY2022Q1	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	257815	USD
CY2021Q4	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	414241	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8743	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8545	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	83585	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	81001	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3826606	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3097320	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	68153	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	125385315	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	124915560	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	464466	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16444	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16814	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20924	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	3596909	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	2786667	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1914483	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-109605997	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-107704274	USD
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	911516	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2749299	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	911516	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	14935955	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16367923	USD
CY2022Q1	us-gaap	Minority Interest MinorityInterest	-170043	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	-152541	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14765912	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16215382	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19065176	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19809744	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2700902	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2924707	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1018476	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1122413	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	1682426	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	1802294	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3115629	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-984373	USD
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4742	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2535	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1919225	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-986908	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	250	USD
CY2022Q1	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1919225	USD
CY2021Q1	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-987158	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1301	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1919225	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-985857	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-17502	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-12988	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1901723	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-972869	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69013001
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66578435
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69013001
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66578435
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16215382	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	305370	USD
CY2022Q1	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	164385	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1919225	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14765912	USD
CY2022Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-0	USD
CY2021Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1301	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	120341	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-101895	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	269973	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	267300	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	258395	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-399630	USD
CY2022Q1	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	-92007	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16106968	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	113507	USD
CY2021Q1	mlss	Stock To Be Issued During Period Value Sharebased Compensation StockToBeIssuedDuringPeriodValueSharebasedCompensation	7	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	690190	USD
CY2021Q1	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	100000	USD
CY2021Q1	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	3012216	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-985857	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19037089	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1919225	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-985857	USD
CY2022Q1	us-gaap	Depreciation Depreciation	3388	USD
CY2021Q1	us-gaap	Depreciation Depreciation	9572	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13426	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11352	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	305370	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	113507	USD
CY2022Q1	mlss	Sharebased Compensation Bonus Paid In Stock SharebasedCompensationBonusPaidInStock	164385	USD
CY2021Q1	mlss	Sharebased Compensation Bonus Paid In Stock SharebasedCompensationBonusPaidInStock	115000	USD
CY2022Q1	mlss	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	-17378	USD
CY2021Q1	mlss	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	1883	USD
CY2021Q1	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	338995	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	246720	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	272905	USD
CY2022Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-231668	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-211072	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	733062	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-200778	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-81797	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	339518	USD
CY2022Q1	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	-156427	USD
CY2021Q1	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	-204107	USD
CY2022Q1	mlss	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-19442	USD
CY2021Q1	mlss	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1507508	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-967814	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5916	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5916	USD
CY2022Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3012216	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2063	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1883	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	690190	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2063	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3700523	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1509571	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2726793	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14764346	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14223917	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13254775	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16950710	USD
CY2022Q1	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60	pure
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-109600000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1900000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	34000	USD
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	580142	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><em style="font: inherit;">3.</em></b> <b> Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to the allowance for doubtful accounts, inventory valuation, and cash flow assumptions regarding evaluations for impairment of long-lived assets and going concern considerations, stock compensation expense, and valuation allowances on deferred tax assets. Actual results could differ from those estimates<b>.</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	178648	USD
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	12400000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	13900000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	79339	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	1799908	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	1541513	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69013001
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66578435
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7543252
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6092193
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1113671	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	264192	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1100244	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	277619	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	40000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	52000	USD
CY2022Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	1200000	USD
CY2021Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	1300000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	28000	USD
CY2022Q1	mlss	Finitelived Intangible Asset Expected Amortization After Year Three FinitelivedIntangibleAssetExpectedAmortizationAfterYearThree	110000	USD
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4268221
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.18
CY2021	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P1Y6M
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1187546	USD
CY2022Q1	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	0
CY2022Q1	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0
CY2022Q1	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	-0
CY2022Q1	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	0
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4268221
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.18
CY2022Q1	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P1Y3M
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2700902	USD
CY2021Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2066343
CY2020Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2440878
CY2022Q1	mlss	Deferred Compensation Arrangement With Individual Shares Granted DeferredCompensationArrangementWithIndividualSharesGranted	108148
CY2021Q1	mlss	Deferred Compensation Arrangement With Individual Shares Granted DeferredCompensationArrangementWithIndividualSharesGranted	33238
CY2022Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	-0
CY2021Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	65965
CY2022Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2174491
CY2021Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2408151
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q1	mlss	Percentage Of Valuation Allowance PercentageOfValuationAllowance	1	pure
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2924707	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1914483	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-984373	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16814	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20924	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1919225	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-986908	USD
CY2022Q1	us-gaap	Assets Assets	19065176	USD
CY2021Q4	us-gaap	Assets Assets	19809744	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2700902	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2924707	USD
CY2022Q1	mlss	Lease Liability Current LeaseLiabilityCurrent	83585	USD
CY2005Q1	mlss	Additional Percentage Of Director Compensation On Sales Value Using Certain Specify Technology AdditionalPercentageOfDirectorCompensationOnSalesValueUsingCertainSpecifyTechnology	0.025	pure
CY2022Q1	mlss	Lease Rightofuse Asset LeaseRightofuseAsset	528907	USD
CY2022Q1	mlss	Lease Liability LeaseLiability	538441	USD
CY2022Q1	mlss	Lease Liability Noncurrent LeaseLiabilityNoncurrent	454857	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	26544	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8743	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	17801	USD
CY2021Q4	mlss	Lease Rightofuse Asset LeaseRightofuseAsset	550511	USD
CY2021Q4	mlss	Lease Liability LeaseLiability	577981	USD
CY2021Q4	mlss	Lease Liability Current LeaseLiabilityCurrent	81001	USD
CY2021Q4	mlss	Lease Liability Noncurrent LeaseLiabilityNoncurrent	476980	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	28607	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8545	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	20062	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	31882	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	31303	USD
CY2022Q1	mlss	Finance Lease Principal Payments Including Accrued Expenses FinanceLeasePrincipalPaymentsIncludingAccruedExpenses	2685	USD
CY2021Q1	mlss	Finance Lease Principal Payments Including Accrued Expenses FinanceLeasePrincipalPaymentsIncludingAccruedExpenses	2685	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	663009	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	43242	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		USD
CY2005Q1	mlss	Additional Percentage Of Director Compensation Sales Value Using Other Kind Of Technology AdditionalPercentageOfDirectorCompensationSalesValueUsingOtherKindOfTechnology	0.05	pure
CY2021Q1	mlss	Additional Percentage Of Director Compensation Sales Value Using Other Kind Of Technology AdditionalPercentageOfDirectorCompensationSalesValueUsingOtherKindOfTechnology	0.025	pure

Files In Submission

Name	View Source	Status
0001437749-22-012645-index-headers.html	Edgar Link	pending
0001437749-22-012645-index.html	Edgar Link	pending
0001437749-22-012645.txt	Edgar Link	pending
0001437749-22-012645-xbrl.zip	Edgar Link	pending
ex_358335.htm	Edgar Link	pending
ex_358336.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mlss-20220331.xsd	Edgar Link	pending
mlss-20220331_cal.xml	Edgar Link	unprocessable
mlss-20220331_def.xml	Edgar Link	unprocessable
mlss-20220331_lab.xml	Edgar Link	unprocessable
mlss-20220331_pre.xml	Edgar Link	unprocessable
mlss20220331_10q.htm	Edgar Link	pending
mlss20220331_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

2022 Q1 Form 10-Q Financial Statement

#000143774922012645 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS MILESTONE SCIENTIFIC INC. Stock $mlss

2022 Q1 Form 10-Q Financial Statement

#000143774922012645 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss